Støre gratulerar Andersson efter det svenska valresultatet

json
{
”subject”: ”Ribociclib API Supply Partnership for Berko’s CDK4/6 Pipeline”,
”content”: ”

I noted Berko’s expanding pharmaceutical portfolio and contract manufacturing operations across 23 markets, combined with your GMP-certified 21,000 m² facility, which positions your company to leverage the upcoming ribociclib patent cliff. As the CDK4/6 inhibitor market grows toward blockbuster status, securing a reliable, DMF/CEP-supported API source now is critical for a smooth transition from development through global registration.

Unibest Industrial Co., Ltd. supplies high-purity Ribociclib API (UBX11) with full regulatory documentation packages. Our GMP-compliant production, robust nitrosamine controls, and scalable capacity (from pilot batches to commercial volumes) directly address the technical and quality requirements of Berko’s oncology pipeline. We provide comprehensive DMF/CEP/ASMF support to align with your registration strategy in the US, EU, and other target markets, ensuring timely regulatory filings ahead of the 2029 compound patent expiry.

Given your active presence in regulated markets and the projected launch window, we offer competitive pricing, FTA/CMP delivery options, and technical assistance for formulation trials. This enables Berko to minimize supply-chain risks, reduce total procurement costs, and optimize time-to-market for this high-value API.

May I send our detailed specification dossier, sample, and a proposed commercial quotation for your team’s evaluation? We are prepared to arrange a technical call or site visit at your convenience and would welcome the opportunity to discuss registration milestones, packaging preferences, and annual volume requirements.

For more product information, please visit: Chemical Compositions, Biological Ingredients

”
}